Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/disopyramide-in-the-prevention-of-recurrence-of-atrial-fibrillation-SKhjBEnaEd
References (12)
-
Gottfried Hirtell, Antti Louhija, Aarne Konttinen, P. Halonen (1970)
Value of quinidine in maintenance of sinus rhythm after electric conversion of atrial fibrillation.British Heart Journal, 32
-
(1968)
Etude clinique d'un novel anti-arythmique, Ie disopyramide -
(1970)
Maintenance of sinus rhythm after DC reversion of atrial fibrillation -
M. Katz, C. Meyer, A. El-Etr, S. Slodki (1963)
Clinical evaluation of a new anti-arrhythmic agent, SC-7031.Current therapeutic research, clinical and experimental, 5
-
(1972)
La reduction des fibrillations auricularies par Ie disopyram - ide , Coeur Med -
(1968)
Action du disopyramide dans Ie traitement des troubles du rythme cardiaque -
L. Hillestad, C. Bjerkelund, J. Dale, J. Maltau, O. Storstein (1971)
Quinidine in maintenance of sinus rhythm after electroconversion of chronic atrial fibrillation. A controlled clinical study.British Heart Journal, 33
-
Pershotam Mathur (1972)
Cardiovascular effects of a newer antiarrhythmic agent, disopyramide phosphate.American heart journal, 84 6
-
A. Sekiya, E. Vaughan-Williams (1963)
A COMPARISON OF THE ANTIFIBRILLATORY ACTIONS AND EFFECTS ON INTRACELLULAR CARDIAC POTENTIALS OF PRONETHALOL, DISOPYRAMIDE AND QUINIDINE.British journal of pharmacology and chemotherapy, 21
-
L. Resnekov, L. Mcdonald (1965)
PULMONARY OEDEMA FOLLOWING TREATMENT OF ARRHYTHMIAS BY DIRECT-CURRENT SHOCK.Lancet, 1 7384
-
(1962)
Pharmacology of a new antiarrhythmic agent , y - diisopropyl - amino - a - phenyl - a - ( 2 - pyridyl ) - butyramide ( SC - 7031 ) -
P. Szekely, D. Sideris, G. Batson (1970)
Maintenance of sinus rhythm after atrial defibrillation.British Heart Journal, 32
- Publisher
- Wiley
- Copyright
- © American Society for Clinical Pharmacology and Therapeutic
- ISSN
- 0009-9236
- eISSN
- 1532-6535
- DOI
- 10.1002/cpt1974156551
- Publisher site
- See Article on Publisher Site
Abstract
The effect of a new antidysrhythmic drug, disopyramide, was tested in a double‐blind clinical trial in 52 patients undergoing electroconversion of atrial fibrillation. During a 3 month follow‐up, the number of patients remaining in sinus rhythm after successful electroconversion was higher (p < 0.05) in the disopyramide group (72%) than in the placebo group (30%).
Journal
Clinical Pharmacology & Therapeutics – Wiley
Published: Jun 1, 1974